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Abstract
Background: To determine the accuracy of serum-effusion albumin gradient (SEAG) and pleural
fluid to serum albumin ratio (ALBR) in the diagnostic separation of pleural effusion into transudate
and exudate and to compare SEAG and ALBR with pleural fluid LDH (FLDH) the most widely used
test.
Methods: Data collected from 200 consecutive patients with a known cause of pleural effusion in
a United Kingdom district general hospital.
Results: The median and inter quartile ranges (IQR) for SEAG 93.5 (33.8 to 122.5) g/dl, ALBR 0.49
(0.42 to 0.62) and FLDH 98.5 IU/L(76.8 to 127.5) in transudates were significantly lower than the
corresponding values for exudates 308.5 (171 to 692), 0.77 (0.63 to 0.85), 344 (216 to 695) all p <
0.0001. The Area Under the Curve (AUC) with 95% confidence intervals (Cl) for SEAG, ALBR and
FLDH were 0.81 (0.75 to 0.87), 0.79 (0.72 to 0.86) and 0.9 (0.87 to 0.96) respectively. The positive
likelihood ratios with 95%CI for FLDH, SEAG, and ALBR were: 7.3(3.5–17), 6.3(3–15) 6.2(3–14)
respectively. There was a significant negative correlation between SEAG and ALBR (r= -0.89, p <
0.0001).
Conclusion: The discriminative value for SEAG and ALBR appears to be similar in the diagnostic
separation of transudates and exudates. FLDH is a superior test compared to SEAG and ALBR.
Background
Pleural effusion is a common clinical problem resulting
from thoracic or systemic diseases. An effusion is termed
as transudate when its formation is due to alterations in
the mechanical factors such as increased pulmonary hy-
drostatic pressure or decreased plasma oncotic pressure
[1, 2]. An e ffusion is classifie d as an ex udat e when the
pleural fluid is formed because of loss of pleural surface
integrity by inflammatory or infiltrative processes causing
an increase in microvascular permeability [1,3].
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Based on this principle pleural fluid is termed an exudate
if fluid to serum total protein ratio (TPR) is ≥  0.5, or the
pleural fluid absolute value of FLDH is ≥  200 IU/L, or the
fluid to serum ratio of LDH value (LDHR) is ≥  0.6. An ef-
fusion is classified as a transudate if the TPR is <0.5, FLDH
is <200 IU/L, and the LDHR is <0.6 [4]. Roth and associ-
ates have documented that serum-effusion gradient of al-
bumin is a better discriminator than Light's criteria in the
diagnostic separation of transudates and exudates [5]. On
the other hand, Burgess et. al. [6] using an albumin gradi-
ent of 12 g/L found the sensitivity and specificity to be
87% and 92% respectively and concluded that the criteria
by Light et. al [4] remained the best method for distin-
guishing exudates from transudates. It is worth noting
here that both studies used conventional analysis and not
Receiver Operating Characteristics (ROC).
Recently, we have established that FLDH and TPR perform
better and that fluid to serum ratio of LDH (LDHR) had
no role in the diagnostic separation of transudates and ex-
udates using ROC analysis [7]. Therefore, this study was
undertaken to compare the accuracy of serum-effusion al-
bumin gradient (SEAG) and fluid to serum albumin ratio
(ALBR) with the best available criteria i.e. FLDH from our
previous report using ROC [7].
Materials & Methods
Patients referred for evaluation of pleural effusion to the
respiratory unit at Rotherham Trust hospital, United King-
dom, from January 1989 to June 1991 for a prospective
investigation of the dynamics of pleural effusion forma-
tion and removal were included in the study [8]. The
cause of pleural effusion and their diagnostic separation
was determined using clinical criteria set by Light and as-
sociates [4]. All patients were followed for at least 3
months or till the final cause of the pleural effusion was
established. During the study, pleural effusion samples
from two hundred and twelve (212) consecutive patients
were collected. However, eight patients with uncertain di-
agnosis and four patients with possible multiple causes
for the pleural effusion were excluded from the analysis.
Effusions due to pulmonary embolism were classified as
exudates according to Burgess et al [6].
Blood and pleural effusion samples collected and stored
at -80°C were analyzed within a period of six months for
albumin, total protein and LDH level. The pleural fluid
and the corresponding serum samples were drawn simul-
taneously at the time of admission before any treatment
was administered. LDH was measured with Boehringer
Mannheim kit according to established methods and re-
sults expressed in IU/L [9]. The upper limit for the normal
serum LDH value in our laboratory during the study was
200 IU/L. SEAG was calculated by subtracting the pleural
fluid albumin value from serum albumin value.
Statistical analysis
The median values for SEAG, ALBR and FLDH were com-
pared in transudates and exudates using Mann-Whitney U
test. A p-value of <0.05 was considered significant. To
compare the performance of SEAG, ALBR and FLDH in
the diagnostic separation of transudates and exudates,
ROC curves were generated for each of the criteria by plot-
ting the true positive value (sensitivity) against the false
positive value (1- specificity) for multiple test results. Area
under the curve (AUC) with 95% confidence intervals was
calculated using Wilcoxon estimate. The AUC for the three
tests were compared using the method described by
Hanley and McNeil [10]. Furthermore, to account for
multiple comparisons, we performed Bonferoni's correc-
tion of the final p value. Optimum cut-off points for
SEAG, ALBR and FLDH were computed by using the sta-
tistical software StatsDirect (www.statsdirect.com) taking
the best possible values for sensitivity and 1-specificity on
the ROC plot. Finally, the correlation between SEAG and
ALBR was estimated using Pearson's correlation. Data on
age is presented as mean ± standard deviation and other
test variables are presented as median and interquartile
range (IQR) as they are not distributed normally.
Results
Of the 200 patients with pleural effusion, 116 were males
and 84 were females. The mean age ± standard deviation
was 62 ± 15. One hundred and fifty six (78%) effusions
were exudates. The causes for the pleural effusion were:
thoracic malignancy 90, thoracic infection including em-
pyema 37, pulmonary embolism 11, pancreatitis 6, au-
toimmune disease 5, other exudates 7, cardiac failure 37,
chronic liver disease 5, and nephrotic syndrome 2. The
median and IQR for SEAG, ALBR and FLDH are given in
table 1. The median value for all three tests in transudates
and exudates were significantly different.
The ROC plots for SEAG, ALBR and FLDH are shown in
figure-1. At all test values, FLDH was more sensitive and
specific than SEAG and ALBR. The optimum cut-off levels
were 163IU/L for FLDH, 9 g/L for SEAG, and 0.68 for
ALBR respectively. FLDH was the best of the three tests.
The AUC and the corresponding 95% Cl for SEAG, ALBR
and FLDH were 0.81 (0.75 to 0.87), 0.79 (0.72 to 0.86)
and 0.9 (0.87 to 0.96) respectively. Although the AUC for
SEAG and ALBR were of similar magnitude, the AUC for
FLDH was significantly more than the AUC for ALBR (z =
2.75, p < 0.01). Of the 156 exudates, FLDH correctly clas-
sified 132 (85%) 95% Cl 0.78–0.90, SEAG 112 (72%)
0.64–0.79, and ALBR 111 (71%) 0.63–0.78 respectively
as exudates and all three tests classified 39 (89%) 0.75–
0.96 of the 44 transudates correctly. Table 2 lists the posi-
tive likelihood ratios (LR +ve) with 95% Cl for the three
tests at the optimum cut-off level. Figure-2 shows the cor-
relation between SEAG and ALBR. There was a significantBMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/1
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negative correlation between the two tests (r = -0.89, p <
0.0001).
Discussion
Pleural effusion is a common clinical problem and it's di-
agnostic approach has been simplified by characterizing
effusion into transudate and exudate [11]. Several bio-
chemical markers have been used in the past for this pur-
pose [12–14]. However, TPR and FLDH have remained
the most widely used criteria so far. Therefore, this study
was undertaken to assess the global performance of SEAG
and ALBR with the existing best criteria i.e. FLDH [7]. The
strength of our study is that we have utilized ROC analysis
for comparing different tests. Furthermore, ROC analysis
provides an opportunity to calculate likelihood ratios at
various cutoff points of the diagnostic test. The upper lim-
it of the normal LDH varies according to the methods
used for estimating lactate dehydrogenase. In this study
we have used the Boehringer Mannheim kit and the upper
normal for this method is 200IU//L [9].
In our present study, the mean age and causes of pleural
effusion were similar to that of Roth et al. [5]. However,
the mean SEAG value of 14 g/L for transudate and 8 g/L
Table 1: Median and Interquartile range (IQR) for the three tests
Test Transudate (n = 44) IQR Exudate (n = 156) IQR P value *
SEAG (g/L) 93.5 33.8–122.5 308.5 171–692 0.0001
ALBR 0.49 0.42–0.62 0.77 0.63–0.85 0.0001
FLDH (IU/L) 98.5 76.8–127.5 344 216–695 0.0001
* Mann-Whitney U test
Figure 1
Receiver Operating Characteristic plots of the pleural fluid
FLDH, ALBR, and SEAG. The optimum cut-off level was
determined by selecting the points of test values that pro-
vided the greatest sum of sensitivity and specificity. The opti-
mum cutoff for FLDH was 163 IU/L, ALBR = 0.68, SEAG =
9.0.
Figure 2
Association between ALBR and SEAG in pleural effusion
Table 2: Positive Likelihood Ratios (LR) at optimum cut-off 
points
Test LR 95% CI
FLDH 7.3 3.5 to 17
SEAG 6.3 3 to 15
ALBR 6.2 3 to 14BMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/1
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for exudate in our series were different from that provided
by Roth and associates about 20 g/L for transudates and
0.75 g/L for exudates. From ROC analysis it is clear that
FLDH performed better compared to SEAG and ALBR as
documented by the highest value for the AUC. ALBR has
been reported to be inferior to SEAG in the diagnostic sep-
aration of transudates and exudates [5]. However, in our
analysis the accuracy of ALBR and SEAG were similar as
evidenced by similar AUC and positive LR. Furthermore,
correlation analysis between SEAG and ALBR has shown a
significant negative correlation (0.89).
As the level of pleural fluid albumin increases depending
on the degree of pleural microvacular injury in exudative
processes, the ALBR increases correspondingly. Whereas,
pleural fluid to SEAG is highest in transustive effusions as
less albumin is filtered through the relatively normal pleu-
ral microvasculature. However, as pleural microvascula-
ture is damaged in exudative processes, the level of
albumin leaking into the pleural cavity would progressive-
ly increase depending on the degree of injury. Thus a very
low SEAG can be expected in a trasudative processes with
a correspondingly higher ALBR. This would partly explain
the significant negative correlation observed between
SEAG and ALBR thus indicating that these two tests likely
to be operating through the same mechanism [15].
In our study using 9 g/L as the optimum cutoff level for
SEAG, 51 of the 156 exudates were incorrectly labeled as
transudates (false negative) and 5 of the 44 transudates
were labeled as exudates (false positives). There were no
trends for any specific diseases clustering in either of the
groups.
The pathophysiology of transudative or exudative pleural
effusion in humans is not well studied. We have previous-
ly documented that the rate of formation and absorption
are different in different disease states causing pleural ef-
fusion [8]. The decreased concentration of total protein
and albumin in transudates can be explained by the selec-
tive sieving of these macromolecules by the normal intact
microvasculature in transudates [3]. However, animal and
human studies have shown that increase in hydrostatic
pressure can increase the protein content in effusions
[16,17]. This is partly explained by the opening up of large
pores in endothelium with elevated hydrostatic pressure
[18,19]. Thus in a patient with pleural effusion from con-
gestive heart failure, it is possible that the amount of pro-
tein in the pleural fluid can increase significantly to
exudative levels if the degree of pulmonary artery pressure
causing the formation of effusion was very high. Such a
linear correlation between the hydrostatic pressure and
the protein content of ascites in patients with portal hy-
pertension has been documented [17]. Therefore, this
phenomenon may help explain the pathogenesis of exu-
dative effusions documented in congestive heart failure
when total protein in pleural effusion was used as a diag-
nostic criteria [5,20,21].
The dynamics of LDH in the pleural cavity is not well stud-
ied. Our recent investigation into the dynamics of pleural
fluid LDH has documented that there was no correlation
between serum and pleural fluid LDH concentration in
transudates or exudates [7]. This compartmentalized ele-
vation of LDH concentration in pleural cavity in exudative
processes help explain the superior performance of FLDH
as a diagnostic test in the separation of pleural effusion
into transudate and exudate compared to SEAG, ALBR.
We have reported earlier that LDHR has no role in the di-
agnostic separation of transudates and exudates. Further-
more, FLDH is the most accurate marker and combining
TPR with FLDH improves the diagnostic utility marginally
[7].
Conclusion
The discriminative value for SEAG and ALBR appears to be
similar in the diagnostic separation of transudates and ex-
udates. FLDH is a superior test compared to SEAG and AL-
BR. Based on these results, SEAG and ALBR appear to have
limited diagnostic utility in clinical practice.
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